Press release
Bioinformatics Market: Technological Innovations, Product Extensions, and Strategies Adopted by Key Vendors till 2027 | Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands)
Bioinformatics Market worth $18.7 billion by 2027 - Exclusive Report by MarketsandMarkets™
Bioinformatics is a rapidly emerging market in the healthcare industry. Bioinformatics is the science of using computers to analyze and interpret biological data. It is used to understand and analyze genetic information, identify potential drugs and treatments, and predict disease progression and outcomes.
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=39&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Bioinformatics has become increasingly important in healthcare due to the development of new technologies and the ability to collect and store massive amounts of data. Healthcare providers rely on bioinformatics to identify trends in patient care, assess genetic risk factors, and develop treatments.
The market is also driven by increasing investments in healthcare data analytics and artificial intelligence. Governments, hospitals, and private companies are investing heavily in bioinformatics to improve health outcomes and reduce costs.
Bioinformatics is an emerging market with a lot of potential for growth. As the technology continues to mature, it will open up new opportunities for healthcare providers and patients. The ability to use data to tailor treatments and predict outcomes will revolutionize the way healthcare is delivered.
TOP BIOINFORMATICS MARKET PLAYER
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), DNASTAR (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.
THERMO FISHER SCIENTIFIC, INC. (US)
Thermo Fisher Scientific, Inc. is the leading player in the bioinformatics market. The company mainly develops technologically advanced bioinformatics solutions to outstand its offerings. It invests into organic and inorganic growth strategies like acquisitions to strengthen its market presence.
PERKINELMER, INC. (US)
PerkinElmer is one of the leading players in the global bioinformatics market. The company provides data analytics, computing, and scientific application software services. PerkinElmer competes in this market based on services offered, price, technological innovation, operational efficiency, product differentiation, product availability, quality, and reliability. The company has a strong geographical presence in the Americas, Europe, Asia, and Africa.
PerkinElmer has a strong sales and distribution network in more than 150 countries for its products and services. These factors are expected to help PerkinElmer stay competitive in the bioinformatics market.
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=39&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
ILLUMINA, INC. (US)
Illumina, Inc. is holds strong position in the bioinformatics market. Illumina has a wide range of product and service portfolio for the end users in this market, a well-established distribution network, and has geographic presence worldwide. With its diverse product offerings, the company is expected to witness high growth in this market.
"North American bioinformatics market to dominate the market during the forecast period"
North America dominated the bioinformatics market in 2021 and is expected to grow at an 12.7% CAGR during the forecast period. The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America.
Recent Developments:
• In October 2022, Illumina, Inc. and AstraZeneca formed a strategic research collaboration to expedite the discovery of therapeutic targets by combining their strengths in AI-based genome interpretation and genomic analysis tools with industry knowledge. The cooperation would assess if a framework made of both these technologies can boost target discovery yield and confidence in order to identify prospective therapeutics based on human omics insights.
• In September 2022, Thermo Fisher Scientific joined the Pennsylvania Biotechnology Center (PABC) as a founding sponsor of both the Philadelphia-based B+Labs incubator and the PABC site in Doylestown, Pennsylvania, where emerging life science enterprises can accelerate their progress to commercialization.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=39&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/bioinformatics-market.asp
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioinformatics Market: Technological Innovations, Product Extensions, and Strategies Adopted by Key Vendors till 2027 | Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands) here
News-ID: 3021188 • Views: …
More Releases from MarketsandMakets
Wire & Cable Market worth $266.2 billion by 2029
The report "Wire & Cable Market by Product Type (Electronic Wire, Power Cable, Control & Instrumentation Cable, Communication Cable, Flexible & Specialty Cable), Material Type, Voltage, Installation, End-Use Industry, and Region - Global Forecast to 2029", wire & cable market is estimated at USD 201.0 billion in 2024 and is projected to reach USD 266.2 billion by 2029, at a CAGR of 5.8% from 2024 to 2029.
Browse in-depth TOC on…
Future of Healthcare Biometrics Market: Development, Industry Size, Key Players, …
Biometrics as a Service in Healthcare Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 20.7% from 2023 to 2028 according to a new report by MarketsandMarkets™.
The amalgamation of biometric data with cutting-edge analytics and artificial intelligence (AI) has emerged as a transformative force within the healthcare sector, significantly bolstering market…
Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMar …
Clinical Communication & Collaboration Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion by 2029, growing at a CAGR of 13.2% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the clinical communication and collaboration market is driven by high prevalence of chronic diseases, rising prominence of big data and mHelath tools, and stringent…
Exploring Market Surge: Impact of Booming Computer Vision Healthcare Market on I …
Computer Vision in Healthcare Market in terms of revenue was estimated to be worth $3.9 billion in 2024 and is poised to reach $11.5 billion by 2029, growing at a CAGR of 24.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The market's expansion is fueled by the exponential growth of medical imaging data which necessitates efficient analysis methods, where computer vision techniques excel in automating and enhancing…
More Releases for Bioinformatics
Bioinformatics Platforms Market Size Analysis by Application, Type, and Region: …
According to Market Research Intellect, the global Bioinformatics Platforms market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The bioinformatics platforms market is witnessing robust growth, fueled by the rising demand for advanced data analytics in…
Bioinformatics Market - Pioneering Solutions for Personalized Healthcare: Bioinf …
Newark, New Castle, USA: The "Bioinformatics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Bioinformatics Market: https://www.growthplusreports.com/report/bioinformatics-market/7618
This latest report researches the industry structure, sales, revenue, price and…
Bioinformatics Market - Analyzing Complexity, Unleashing Potential: Elevating Re …
Newark, New Castle, USA - new report, titled Bioinformatics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Bioinformatics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Bioinformatics market. The report offers an overview of the market, which briefly describes the…
Bioinformatics Market: Increasing Funding and Investments in Bioinformatics
In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals,…
Bioinformatics Market: Increasing Funding and Investments in Bioinformatics
In the field of genetics and genomics, bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a key role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and, more generally, in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals,…
Bioinformatics Market Research Report 2022 | AFFYMETRIX, INC., GENEVA BIOINFORMA …
Global Report on Bioinformatics Market Size, Status, Growth and Forecast 2021-2027.
The " Bioinformatics Market " research report is a valuable source of agile information for business methodologies. It provides an overview of the Bioinformatics industry, providing development research and definitive future value, income, market size, and supply and demand data (if applicable). The exam experts give you a point for each chain and retailer research of significant value. This market study provides extensive information to…
